Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P950022/S153

UltiSynq Defibrillation lead; SurGrip Suture Sleeve Accessory

ABBOTT MEDICAL · Decision date Nov 5, 2026

MEDTECHLEDGER EXPLANATIONP950022/S153

What did the FDA approve?

FDA record P950022/S153 is an approved supplement to PMA P950022 for Abbott Medical, not a new PMA. The supplied record states approval for the UltiSynq™ Defibrillation lead and the SurGrip™ Suture Sleeve Accessory, so the action is tied to those named components rather than to a new device system scope.

The supplement type is “Normal 180 Day Track,” and the listed reason is “Change Design/Components/Specifications/Material.” The source does not describe the exact design, component, specification, or material changes, so the specific modified item beyond those field labels is not stated in the supplied record.

FDA approval order statement

approval for UltiSynq Defibrillation lead and the SurGrip Suture Sleeve Accessory
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Nov 5, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P950022/S153
Regulatory pathway
PMA supplement
Product code
LWS
Decision code
APPR
Decision date
Nov 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implantable cardioverter defibrillator (non-CRT).

Product code
LWS
FDA device class
3

For the original device and its historical approval scope, see PMA P950022. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P950022 · Original PMA

    TVL(TM) LEAD SYSTEM

  2. P950022/S153 received

    Application receipt date recorded by FDA.

  3. P950022/S153 · FDA decision

    Normal 180 Day Track

Timeline entries are records held by MedtechLedger for P950022. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P950022

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA approvalMay 10, 1996FDA

Explore the linked device profile

Other records with product code LWS

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
15900 Valley View Ct., Sylmar, CA, 91335

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records